Skip to content
10-Q

Quarterly Report

FRAZIER LIFESCIENCES ACQUISITION CORPORATION

0001193125-22-218740

← back to feed
Filed
Aug 11, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow Q2 2022 · Jun 30, 2022 −$566.28K
Operating Cash Flow Q2 2022 · Jun 30, 2021 −$575.6K
Stockholders Equity Q2 2022 · Jun 30, 2022 −$6.18M
Stockholders Equity Q2 2022 · Mar 31, 2022 −$4.97M
Stockholders Equity Q2 2022 · Dec 31, 2021 −$6.36M
Stockholders Equity restated Q2 2022 · Jun 30, 2021 −$9.02M
Stockholders Equity restated Q2 2022 · Mar 31, 2021 −$7.72M
Stockholders Equity restated Q2 2022 · Dec 31, 2020 −$10.54M
Current Liabilities Q2 2022 · Jun 30, 2022 $1.83M
Current Liabilities Q2 2022 · Dec 31, 2021 $222.07K
Total Liabilities Q2 2022 · Jun 30, 2022 $7.05M
Total Liabilities Q2 2022 · Dec 31, 2021 $7.86M
Current Assets Q2 2022 · Jun 30, 2022 $765.16K
Current Assets Q2 2022 · Dec 31, 2021 $1.49M
Total Assets Q2 2022 · Jun 30, 2022 $138.9M
Total Assets Q2 2022 · Dec 31, 2021 $139.51M
Sga Expense Q2 2022 · Jun 30, 2022 $1.96M
Sga Expense Q2 2022 · Jun 30, 2022 $2.28M
Sga Expense Q2 2022 · Jun 30, 2021 $275.24K
Sga Expense Q2 2022 · Jun 30, 2021 $482.48K
Net Income Q2 2022 · Jun 30, 2022 −$1.17M
Net Income Q2 2022 · Jun 30, 2022 $211.74K
Net Income Q2 2022 · Mar 31, 2022 $1.38M
Net Income Q2 2022 · Jun 30, 2021 −$1.3M
Net Income Q2 2022 · Jun 30, 2021 $1.52M
Net Income Q2 2022 · Mar 31, 2021 $2.82M
Operating Income Q2 2022 · Jun 30, 2022 −$1.99M
Operating Income Q2 2022 · Jun 30, 2022 −$2.34M
Operating Income Q2 2022 · Jun 30, 2021 −$305.24K
Operating Income Q2 2022 · Jun 30, 2021 −$542.48K